MORGAN CARROLL: Open Payments
NPI 1447617543 · ABILENE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,882 in 111 payments from 16 companies in 2025. Trend: 2023 $2,231 · 2024 $2,661 · 2025 $2,882
Food & beverage: $2,712Education: $170
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 12 | $468 |
| ABBVIE INC. | 22 | $457 |
| UCB, Inc. | 11 | $336 |
| Novartis Pharmaceuticals Corporation | 13 | $315 |
| Regeneron Healthcare Solutions, Inc. | 9 | $289 |
| Janssen Biotech, Inc. | 10 | $236 |
| E.R. Squibb & Sons, L.L.C. | 8 | $216 |
| Galderma Laboratories, L.P. | 8 | $182 |
| GENZYME CORPORATION | 4 | $92 |
| Amgen Inc. | 3 | $66 |
Products named: ILUMYA, DUPIXENT, Bimzelx, COSENTYX, RINVOQ, TREMFYA, Sotyktu, SKYRIZI.
Industry payments across TX — which companies pay providers there.
